Bariatric Surgery as First-Line Diabetes Treatment Leads to High Rates of Remission in Patients With Obesity Class 1, 2
By Kerry Young
OXON HILL, Md -- November 4, 2017 -- Bariatric surgery caused a notable rate of type 2 diabetes remission for people at the lower end of the obesity scale who were recently diagnosed with the disease, according to a study presented here at Obesity Week 2017, the joint Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS).
In a long-term follow-up study, 31 of 35 (89%) patients met the criteria of diabetes remission, reported Ali Aminian, MD, Cleveland Clinic, Cleveland, Ohio. Previous research has found that long-term diabetes remission after bariatric surgery is usually seen in only one-third of patients.
“However, if we perform surgery as the first-line treatment of diabetes in patients who are not severely obese, almost 90% would have diabetes remission,” said Dr. Aminian.
The study tracked people who fell into obesity class 1 and 2 (body mass index [BMI], <40 kg/m2) and had been diagnosed with type 2 diabetes within 12 months of their surgery. The group had a mean baseline BMI of 37.8 and a mean age of 40.5 years.
The criteria for diabetes remission in the study was a haemoglobin A1C (Hb A1C) level of <6.5% and fasting blood glucose (FBG) <126 mg/dL while off diabetes medications.
Roux-en-Y gastric bypass was the most common treatment (n = 27), followed by sleeve gastrectomy (n = 6), and gastric banding (n = 2).
With a median follow-up of 5 years, a mean BMI reduction of 7 ± 4 kg/m2 and a median excess weight loss of 55% appeared to have led to a significant mean reduction in Hb A1C (7.1 ± 1.5 vs 5.8 ± 0.5%; P< .001), FBG (129.4 ± 53.8 vs 94.6 ± 15.7; P = .001), and diabetes medication requirement (0.7 ± 0.6 vs 0.06 ± 0.2; P< .001).
At this point, 31 out of 35 patients met the remission criteria, with only 2 patients still taking diabetes medications. Another patient had Hb A1C >7% at the last follow-up.
[Presentation title: Bariatric Surgery as a First Line Treatment of Type 2 Diabetes in Patients With Obesity Class I and II: 89% Diabetes Remission in Long-Term Follow-Up. Abstract A5148]
DG News saves you time by delivering a short list of medical stories worthy of your time and attention. Our advanced algorithms rank clinical content based on hundreds of data points to surface the most important medical advances impacting your practice each week.